Mineralys Therapeutics, Inc. ($MLYS)
Filing Information
| Accession Number | 0001672659-26-000036 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 21, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
1,248
Total Value
$17,459.52
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jul 17, 2026 | Exercise/Conversion | 416 | $15.44 | $6,423.04 | 51,800 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jul 17, 2026 | Sale | 416 | $26.53 | $11,036.48 | 51,384 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option | Derivative | Jul 17, 2026 | Exercise/Conversion | 416 | $0.00 | $0.00 | 3,334 | Direct | โ | View Details |